Drug intelligence / Profile preview

depigoid + grasses pollen + olea europaea pollen

Development stage
Unknown
Lead developer
Leti Pharma
Modality
Vaccines & Immunotherapeutics
Administration
Subcutaneous
01

Overview

Depigoid + grasses pollen + olea europaea pollen is a combination immunotherapy product that contains depigmented polymerized extracts of grass pollen and olive tree (olea europaea) pollen. It is used for allergen-specific immunotherapy (subcutaneous immunotherapy, SCIT) in the treatment of allergic rhinitis, rhinoconjunctivitis, and/or allergic asthma caused by sensitization to grass and olive pollen. The depigmentation and polymerization processes reduce IgE binding while maintaining T-cell reactivity, improving tolerability and reducing the risk of systemic allergic reactions compared to native extracts[3][7]. The mechanism of action is immunomodulation—repeated exposure to small quantities of allergens re-trains the immune system to reduce allergic responses over time[2][3][7]. Developed primarily for moderate-to-severe pollen-induced conditions, especially in regions with high grass and olive tree pollen exposure.

Brand names
DepigoidDepigoid DUO
Other names
Depigoid Gräser + Olea europaea pollenDepigoid Grass Mix/olea europaeadepigmented polymerized allergen extracts mixture

Beyond the preview

Go deeper on depigoid + grasses pollen + olea europaea pollen.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on depigoid + grasses pollen + olea europaea pollen.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call